• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延迟心室复极作为一种抗心律失常机制。

Delayed ventricular repolarization as an anti-arrhythmic principle.

作者信息

Vaughan Williams E M

出版信息

Eur Heart J. 1985 Nov;6 Suppl D:145-9. doi: 10.1093/eurheartj/6.suppl_d.145.

DOI:10.1093/eurheartj/6.suppl_d.145
PMID:2417849
Abstract

Depolarization of cardiac muscle is achieved by 'fast inward current' through channels which are inactivated within about 1 ms. When the cells are repolarized the process of inactivation of fast channels is rapidly reversed. The class 1 anti-arrhythmic drugs delay the disappearance of inactivation until long after repolarization is complete. In theory, it should be possible to produce a similar extension of refractory period by delaying the repolarization itself. Quinidine and disopyramide caused minor delays of repolarization, but both were primarily class 1 agents, and in addition had undesirable anticholinergic activity. Amiodarone, already in use for many years as an antianginal drug, prolonged action potential duration (APD) and was shown to have an anti-arrhythmic action in rabbits, dogs and man. Although prolongation of APD lengthens QT, a long QT may be caused by phenomena other than prolonged APD, such as heterogeneity of sympathetic drive. Association of long QT with arrhythmia does not, therefore, invalidate the principle that homogeneously prolonged APD should be anti-arrhythmic. In practice, amiodarone, bretylium, sotalol, thyroidectomy, and long-term beta-blockade prolong APD, and are associated with low incidence of arrhythmia. Many mechanisms controlling cardiac repolarization have been proposed, but how repolarization is delayed by individual agents is not fully elucidated.

摘要

心肌的去极化是通过“快速内向电流”经通道实现的,这些通道在约1毫秒内失活。当细胞复极化时,快速通道的失活过程迅速逆转。1类抗心律失常药物会延迟失活的消失,直到复极化完成很久之后。理论上,通过延迟复极化本身应该有可能产生类似的不应期延长。奎尼丁和丙吡胺会引起轻微的复极化延迟,但两者主要都是1类药物,此外还具有不良的抗胆碱能活性。多年来一直作为抗心绞痛药物使用的胺碘酮,延长了动作电位持续时间(APD),并在兔、犬和人类中显示出抗心律失常作用。虽然APD延长会使QT间期延长,但QT间期延长可能由除APD延长之外的其他现象引起,如交感神经驱动的异质性。因此,长QT与心律失常的关联并不否定均匀延长APD应具有抗心律失常作用这一原则。在实践中,胺碘酮、溴苄铵、索他洛尔、甲状腺切除术和长期β受体阻滞剂会延长APD,并与心律失常的低发生率相关。已经提出了许多控制心脏复极化的机制,但个别药物如何延迟复极化尚未完全阐明。

相似文献

1
Delayed ventricular repolarization as an anti-arrhythmic principle.延迟心室复极作为一种抗心律失常机制。
Eur Heart J. 1985 Nov;6 Suppl D:145-9. doi: 10.1093/eurheartj/6.suppl_d.145.
2
Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.药物诱导的后除极致心律失常作用的电生理学基础及机制
Europace. 2014 Nov;16 Suppl 4:iv39-iv45. doi: 10.1093/europace/euu274.
3
A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.一种预防慢性心力衰竭中致心律失常的新机制:快速Ⅲ相复极解释了与索他洛尔相比,胺碘酮在起搏诱导心力衰竭模型中致心律失常潜在风险低的原因。
Eur J Heart Fail. 2011 Oct;13(10):1060-9. doi: 10.1093/eurjhf/hfr107. Epub 2011 Aug 25.
4
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.复极离散度的降低和复极后不应期的延长解释了奎尼丁在短QT综合征模型中的抗心律失常作用。
J Cardiovasc Electrophysiol. 2007 Jun;18(6):658-64. doi: 10.1111/j.1540-8167.2007.00813.x.
5
Characterization of the non-linear rate-dependency of QT interval in humans.人体QT间期非线性频率依赖性的特征描述。
Europace. 2003 Apr;5(2):163-70. doi: 10.1053/eupc.2002.0297.
6
Contribution of delayed ventricular repolarization to the anti-arrhythmic efficacy of sotalol.心室复极延迟对索他洛尔抗心律失常疗效的作用。
Eur Heart J. 1985 Nov;6 Suppl D:171-4. doi: 10.1093/eurheartj/6.suppl_d.171.
7
Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.抗心律失常药物对心脏浦肯野纤维暂停后复极化的不同作用。
Clin Exp Pharmacol Physiol. 1996 Sep;23(9):825-9. doi: 10.1111/j.1440-1681.1996.tb01187.x.
8
Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.延长QT间期的抗心绞痛药物的抗心律失常及促心律失常特性。
J Cardiovasc Pharmacol Ther. 2004 Sep;9 Suppl 1:S85-97. doi: 10.1177/107424840400900107.
9
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Am J Cardiol. 1994 Nov 1;74(9):896-900. doi: 10.1016/0002-9149(94)90582-7.
10
The coming of age of the class III antiarrhythmic principle: retrospective and future trends.III类抗心律失常药物作用机制的发展历程:回顾与未来趋势
Am J Cardiol. 1996 Aug 29;78(4A):17-27. doi: 10.1016/s0002-9149(96)00449-3.

引用本文的文献

1
Effect of Dapagliflozin Treatment on Index of Cardiac Electrophysiological Balance in Patients With Heart Failure With Reduced Ejection Fraction.达格列净治疗对射血分数降低的心力衰竭患者心脏电生理平衡指标的影响
Ann Noninvasive Electrocardiol. 2025 Sep;30(5):e70101. doi: 10.1111/anec.70101.
2
Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure.恩格列净和达格列净疗法可改善心力衰竭患者的QRS-T角和心脏复极参数。
J Innov Card Rhythm Manag. 2024 Apr 15;15(4):5846-5851. doi: 10.19102/icrm.2024.15044. eCollection 2024 Apr.
3
Hypokalemia promotes late phase 3 early afterdepolarization and recurrent ventricular fibrillation during isoproterenol infusion in Langendorff perfused rabbit ventricles.
低钾血症可促进异丙肾上腺素输注时 Langendorff 灌流兔心室晚期 3 期早期后除极和复发性心室颤动。
Heart Rhythm. 2014 Apr;11(4):697-706. doi: 10.1016/j.hrthm.2013.12.032. Epub 2013 Dec 27.
4
The effects of sotalol on ventricular repolarization during exercise.索他洛尔对运动期间心室复极化的影响。
J Zhejiang Univ Sci B. 2005 Apr;6(4):249-53. doi: 10.1631/jzus.2005.B0249.
5
Computer-based analysis of dynamic QT changes: toward high precision and individual rate correction.基于计算机的动态QT变化分析:迈向高精度和个体化心率校正
Ann Noninvasive Electrocardiol. 2002 Oct;7(4):289-301. doi: 10.1111/j.1542-474x.2002.tb00177.x.
6
A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers.新型III类抗心律失常药物UK-68,798在正常志愿者中的剂量范围研究。
Br J Clin Pharmacol. 1991 Oct;32(4):429-32. doi: 10.1111/j.1365-2125.1991.tb03926.x.